These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 12668795)
1. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Vonk JM; Jongepier H; Panhuysen CI; Schouten JP; Bleecker ER; Postma DS Thorax; 2003 Apr; 58(4):322-7. PubMed ID: 12668795 [TBL] [Abstract][Full Text] [Related]
2. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Ulrik CS; Backer V Eur Respir J; 1999 Oct; 14(4):892-6. PubMed ID: 10573238 [TBL] [Abstract][Full Text] [Related]
3. Irreversible airway obstruction assessed by high-resolution computed tomography (HRCT), exhaled nitric oxide (FENO), and biological markers in induced sputum in patients with asthma. Zhang L; Gang J; Zhigang C; Yali C; Baozhong S; Fangbiao Z; Liu C Wien Klin Wochenschr; 2014 Sep; 126(17-18):515-23. PubMed ID: 25138548 [TBL] [Abstract][Full Text] [Related]
4. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. Demeo DL; Sandhaus RA; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard S; Burchard E; Stocks JM; Stoller JK; Strange C; Turino GM; Campbell EJ; Silverman EK Thorax; 2007 Sep; 62(9):806-13. PubMed ID: 17389752 [TBL] [Abstract][Full Text] [Related]
5. The objective evaluation of obstructive pulmonary diseases with spirometry. Ozkaya S; Dirican A; Tuna T Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884 [TBL] [Abstract][Full Text] [Related]
6. Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype. Konstantellou E; Papaioannou AI; Loukides S; Patentalakis G; Papaporfyriou A; Hillas G; Papiris S; Koulouris N; Bakakos P; Kostikas K Respir Med; 2015 Nov; 109(11):1404-9. PubMed ID: 26412805 [TBL] [Abstract][Full Text] [Related]
7. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. Contoli M; Baraldo S; Marku B; Casolari P; Marwick JA; Turato G; Romagnoli M; Caramori G; Saetta M; Fabbri LM; Papi A J Allergy Clin Immunol; 2010 Apr; 125(4):830-7. PubMed ID: 20227753 [TBL] [Abstract][Full Text] [Related]
8. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease. Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA Respiration; 2011; 82(1):19-27. PubMed ID: 21282939 [TBL] [Abstract][Full Text] [Related]
9. Comparative prevalence of co-morbidities in smoking and non-smoking asthma patients with incomplete reversibility of airway obstruction, non-smoking asthma patients with complete reversibility of airway obstruction and COPD patients. Nadeau M; Boulay MÈ; Milot J; Lepage J; Bilodeau L; Maltais F; Boulet LP Respir Med; 2017 Apr; 125():82-88. PubMed ID: 28340867 [TBL] [Abstract][Full Text] [Related]
10. Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Teeter JG; Bleecker ER Chest; 1998 Feb; 113(2):272-7. PubMed ID: 9498938 [TBL] [Abstract][Full Text] [Related]
11. Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV(1) in primary care patients presenting with a persistent cough? Thiadens HA; De Bock GH; Van Houwelingen JC; Dekker FW; De Waal MW; Springer MP; Postma DS Thorax; 1999 Dec; 54(12):1055-60. PubMed ID: 10567623 [TBL] [Abstract][Full Text] [Related]
12. [FEV1 after three years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease]. Zagdańska R; Grzelewska-Rzymowska I Pneumonol Alergol Pol; 2005; 73(2):142-7. PubMed ID: 16756143 [TBL] [Abstract][Full Text] [Related]
13. Irreversible airway obstruction in childhood asthma? A clinician's viewpoint. König P Pediatr Pulmonol; 2002 Apr; 33(4):307-10. PubMed ID: 11921460 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Rasmussen F; Taylor DR; Flannery EM; Cowan JO; Greene JM; Herbison GP; Sears MR Am J Respir Crit Care Med; 2002 Jun; 165(11):1480-8. PubMed ID: 12045120 [TBL] [Abstract][Full Text] [Related]
15. The relationship between exhaled nitric oxide measured with an off-line method and airway reversible obstruction in Japanese adults with asthma. Tsuburai T; Tsurikisawa N; Taniguchi M; Morita S; Ono E; Oshikata C; Ohtomo M; Maeda Y; Ikehara K; Akiyama K Allergol Int; 2007 Mar; 56(1):37-43. PubMed ID: 17259808 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of asthma combined with COPD feature. Lee HY; Kang JY; Yoon HK; Lee SY; Kwon SS; Kim YK; Rhee CK Yonsei Med J; 2014 Jul; 55(4):980-6. PubMed ID: 24954327 [TBL] [Abstract][Full Text] [Related]